Healthy Infants Clinical Trial
Official title:
Infant Feeding Practice and Gut Comfort: a Multi-country, Cross-sectional Observational Study
NCT number | NCT03703583 |
Other study ID # | 17.12.INF |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 9, 2018 |
Est. completion date | December 31, 2019 |
Verified date | October 2023 |
Source | Société des Produits Nestlé (SPN) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Multi-country, cross-sectional, observational study in diverse geographic locations all over the world.
Status | Completed |
Enrollment | 2804 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 30, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Weeks to 4 Months |
Eligibility | Inclusion Criteria: - Healthy full term (37-42 weeks of gestation) singleton infant. - Postnatal age = 6 weeks and = 4 months - Parent as primary Caregiver and = 18 years old - Exclusively/predominantly breastfeeding or exclusively/predominantly formula feeding of the same type/brand, for at least the past 2 weeks. - Evidence of personally signed and dated informed consent document by the infant's parent(s). Exclusion Criteria: - Chronic illness necessitating medical follow up - Acute ongoing or recent (last 2 weeks) illness necessitating medical follow up - Any known case of food allergy (e.g milk) - Caregivers who are not likely to comply with the study procedures |
Country | Name | City | State |
---|---|---|---|
Egypt | Alexandria University | Alexandria | |
Egypt | Assuit University | Assiut | |
Egypt | Ain Shams University | Cairo | |
Egypt | Cairo University | Cairo | |
Egypt | Tanta University | Tanta | |
Egypt | Zagazig University | Zagazig | |
India | Apollo Children's Hospital | Chennai | |
India | ICH Hospital | Kolkata | |
India | Dr Praveen Gokhales Childrens Clinic and Vaccination Centre | Thane | |
Indonesia | Faculty of Medicine Universitas Gadjah Mada | Yogyakarta | |
Malaysia | University of Malaya | Kuala Lumpur | |
Pakistan | PIMS | Islamabad | |
Pakistan | National Institute of Child Health | Karachi | |
Pakistan | The Children Hospital & Institute of Child Health | Lahore | |
Pakistan | BBH | Rawalpindi | |
Philippines | St.Luke'S College of Medicine | Quezon City |
Lead Sponsor | Collaborator |
---|---|
Société des Produits Nestlé (SPN) |
Egypt, India, Indonesia, Malaysia, Pakistan, Philippines,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | An index score of overall GI symptom burden | Measured by Validated, standardized infant Gastrointestinal Symptom Questionnaire (IGSQ-13) | single time point between 6 weeks to 4 months | |
Secondary | GI Symptoms | measured by IGSQ-13 questionnaires (An overall index score is calculated from 13 questions in the questionnaire as a measure of total GI symptom burden. The values for the IGSQ index score can range from 13 (low GI burden) to 65 (high GI burden)) | single time point between 6 weeks to 4 months | |
Secondary | Stool characteristics | measured by Feeding Practice and Gut Comfort Questionnaire (frequency and consistency) | one day recall before study visit | |
Secondary | Physician-reported and parent-reported Colic | measured by Feeding Practice and Gut Comfort Questionnaire based on ROME IV diagnosis criteria. Effect of feeding group on the prevalence of colic will be assessed by logistic regression. | Single time point between 6 weeks to 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03679234 -
Impact of Infant Formula on Caregiver-perceived Intolerance
|
N/A | |
Completed |
NCT01681355 -
Gastrointestinal Tolerance Study of a New Infant Formula
|
N/A | |
Completed |
NCT04962594 -
Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)
|
N/A | |
Completed |
NCT03722550 -
Second Generation Human Milk Oligosaccharides Blend Study
|
N/A | |
Completed |
NCT01515644 -
Study on the Effect of Inulin in Infant Formula on Gut Health
|
Phase 3 | |
Completed |
NCT03014115 -
Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants
|
N/A | |
Recruiting |
NCT06053112 -
The Trial of a New Infant Formula in Healthy Term Chinese Infants
|
N/A | |
Completed |
NCT03000543 -
Novel Isotope Dilution Technique to Assess Vitamin A Status
|
N/A | |
Not yet recruiting |
NCT06361719 -
Efficacy of Two HMOs in Chinese Infants
|
N/A | |
Terminated |
NCT03976596 -
Measurement of in Vivo Mitochondrial Capacity in Infants
|
||
Recruiting |
NCT01601197 -
A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization
|
Phase 3 | |
Completed |
NCT01635816 -
Immunogenicity of SA 14-14-2 JE Vaccine
|
Phase 4 | |
Completed |
NCT01633216 -
Poliovirus Vaccine Trial in Bangladesh
|
Phase 4 | |
Completed |
NCT00957892 -
Effects of Infant Formula Composition on Infant Feeding Behaviors
|
N/A | |
Completed |
NCT03801161 -
Influence of Inflammation on Micronutrient Status Assessment
|
N/A | |
Active, not recruiting |
NCT06073652 -
Starter Infant Formula With Synbiotics
|
N/A | |
Completed |
NCT01825109 -
Improving Rotavirus Vaccine Immune Response
|
Phase 3 | |
Withdrawn |
NCT01507935 -
Colonisation Resistance Study
|
Phase 2 | |
Completed |
NCT01594840 -
Changing Chat: Diaper Tips to Improve Language Development
|
N/A | |
Not yet recruiting |
NCT01249911 -
Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants
|
Phase 3 |